Isosorbide Dinitrate description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Isosorbide Dinitrate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

ISOSORBIDE DINITRATE DESCRIPTION


Isosorbide Dinitrate








CLINICAL PHARMACOLOGY




PHARMACOKINETICS











INDICATIONS & USAGE



WARNINGS

Amplification of the vasodilatory effects of ISDN by sildenafil can result in severe hypotension. The time course and dose dependence of this interaction have not been studied. Appropriate supportive care has not been studied, but it seems reasonable to treat this as a nitrate overdose, with elevation of the extremities and with central volume expansion.


PRECAUTIONS







ISOSORBIDE DINITRATE CONTRAINDICATIONS



INFORMATION FOR PATIENTS




DRUG INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY



NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



ISOSORBIDE DINITRATE ADVERSE REACTIONS


OVERDOSAGE


OVERDOSAGE














DOSAGE & ADMINISTRATION

CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY



HOW SUPPLIED






















STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Isosorbide Dinitrate

Isosorbide Dinitrate

Isosorbide Dinitrate

Isosorbide Dinitrate TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-442(NDC:0143-1769)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
isosorbide dinitrate ISOSORBIDE DINITRATE 5 mg

Inactive Ingredients

Ingredient Name Strength
AMMONIUM PHOSPHATE, DIBASIC
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
cellulose, microcrystalline
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 8 mm westward;769 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-442-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075659 2011-08-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.